Alginate-based strategies for therapeutic vascularization

Therapeutic Delivery

Volumn 4, Issue 3, 2013, Pages 327-341

  Gandhi, Jarel K ^a   Opara, Emmanuel C ^b   Brey, Eric M ^a,c  

^a Illinois Institute of Technology   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c HINES VA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; ANGIOPOIETIN 1; CHITOSAN; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; SCATTER FACTOR; SOMATOMEDIN C; VASCULOTROPIN;

CELL ENCAPSULATION; CELL PROLIFERATION; CELL THERAPY; CHEMICAL COMPOSITION; COVALENT BOND; DRUG DELIVERY SYSTEM; DRUG PROTEIN BINDING; DRUG RELEASE; HUMAN; HYDROGEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; REVIEW; STRUCTURE ANALYSIS; TISSUE ENGINEERING; VASCULARIZATION; VISCOELASTICITY;

EID: 84874628460     PISSN: 20415990     EISSN: 20416008     Source Type: Journal    
DOI: 10.4155/tde.12.163     Document Type: Review

References (84)

1. Nakatsu MN, Hughes CCW. An optimized three-dimensional in vitro model for the analysis of angiogenesis. Meth. Enzymol. 443, 65-82 (2008).
2. Zetter BR. Angiogenesis and tumor metastasis. Annu. Rev. Med. 49, 407-424 (1998).
3. Ferrara N, Damico L, Shams N, Lowman H, Kim R. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration. Retina 26(8), 859-870 (2006).
4. Kim KJ, Li B, Winer J et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362(6423), 841-844 (1993).
5. Ng Y-S, D'Amore PA. Therapeutic angiogenesis for cardiovascular disease. Curr. Control. Trials. Cardiovasc. Med. 2(6), 278-285 (2001).
6. Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J. Mol. Cell. Cardiol. 33(5), 907-921 (2001).
7. Aguado BA, Mulyasasmita W, Su J, Lampe KJ, Heilshorn SC. Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers. Tissue Eng. Part A 18(7-8), 806-815 (2012).
8. Augst AD, Kong HJ, Mooney DJ. Alginate hydrogels as biomaterials. Macromol. Biosci. 6(8), 623-633 (2006).
9. Ball A, Harding S, Mitchell J. Combined low-speed sedimentation equilibrium gel-permeation chromatography approach to molecular-weight distribution analysis-application to a sodium alginate. Int. J. Biol. Macromol. 10(5), 259-264 (1988).
10. Sperger DM, Fu S, Block LH, Munson EJ. Analysis of composition, molecular weight, and water content variations in sodium alginate using solid-state NMR spectroscopy. J. Pharm. Sci. 100(8), 3441-3452 (2011).
11. Haug A, Larsen B, Smidsrød O. Uronic acid sequence in alginate from different sources. Carbohydr. Res. 32(2), 217-225 (1974).
12. Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog. Polym. Sci. 37(1), 106-126 (2012).
13. Becker TA, Kipke DR. Flow properties of liquid calcium alginate polymer injected through medical microcatheters for endovascular embolization. J. Biomed. Mater. Res. 61(4), 533-540 (2002).
14. Mørch YA, Donati I, Strand BL. Effect of Ca2+, Ba2+, and Sr2+ on alginate microbeads. Biomacromolecules 7(5), 1471-1480 (2006).
15. Jay SM, Saltzman WM. Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking. J. Control. Release 134(1), 26-34 (2009).
16. Aslani P, Kennedy RA. Effect of gelation conditions and dissolution media on the release of paracetamol from alginate gel beads. J. Microencapsul. 13(5), 601-614 (1996).
17. Gombotz WR, Wee SF. Protein release from alginate matrices Adv. Drug Deliv. Rev. 31(3), 267-285 (2012).
18. Fonseca KB, Bidarra SJ, Oliveira MJ, Granja PL, Barrias CC. Molecularly designed alginate hydrogels susceptible to local proteolysis as three-dimensional cellular microenvironments. Acta Biomater. 7(4), 1674-1682 (2011).
19. Drury JL, Dennis RG, Mooney DJ. The tensile properties of alginate hydrogels. Biomaterials 25(16), 3187-3199 (2004).
20. Kong HJ, Smith MK, Mooney DJ. Designing alginate hydrogels to maintain viability of immobilized cells. Biomaterials 24(22), 4023-4029 (2003).
21. Shapiro L, Cohen S. Novel alginate sponges for cell culture and transplantation. Biomaterials 18(8), 583-590 (1997).
22. Opara EC, Mirmalek-Sani SH, Khanna O, Moya ML, Brey EM. Design of a bioartificial pancreas(+). J. Investig. Med. 58(7), 831-837 (2010).
23. Liu Y, Sakai S, Taya M. Production of endothelial cell-enclosing alginate-based hydrogel fibers with a cell adhesive surface through simultaneous cross-linking by horseradish peroxidase-catalyzed reaction in a hydrodynamic spinning process. J. Biosci. Bioeng. 114(3), 353-359 (2012).
24. Moya M, Morley M, Khanna O, Opara E, Brey E. Stability of alginate microbead properties in vitro. J. Mater. Sci. Mater. Med. 23(4), 903-912 (2012).
25. Alshamkhani A, Duncan R. Radioiodination of alginate via covalently-bound tyrosinamide allows monitoring of its fate in vivo. J. Bioact. Compat. Polym. 10(1), 4-13 (1995).
26. Lee KY, Bouhadir KH, Mooney DJ. Evaluation of chain stiffness of partially oxidized polyguluronate. Biomacromolecules 3(6), 1129-1134 (2002).
27. Boontheekul T, Kong H-J, Mooney DJ. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials 26(15), 2455-2465 (2005).
28. Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials 20(1), 45-53 (1999).
29. Rowley JA, Mooney DJ. Alginate type and RGD density control myoblast phenotype. J. Mater. Res. 60(2), 217-223 (2002).
30. Rafat M, Rotenstein LS, Hu JL, Auguste DT. Engineered endothelial cell adhesion via VCAM1 and E-selectin antibody-presenting alginate hydrogels. Acta Biomater. 8(7), 2697-2703 (2012).
31. Amsden B, Turner N. Diffusion characteristics of calcium alginate gels. Biotechnol. Bioeng. 65(5), 605-610 (1999).
32. Amsden B. Solute diffusion within hydrogels Mechanisms and models. Macromolecules 31(23), 8382-8395 (1998).
33. Chinen N, Tanihara M, Nakagawa M et al. Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its release. J. Biomed. Mater. Res. A 67(1), 61-68 (2003).
34. Edelman ER, Mathiowitz E, Langer R, Klagsbrun M. Controlled and modulated release of basic fibroblast growth factor. Biomaterials 12(7), 619-626 (1991).
35. Tanihara M, Suzuki Y, Yamamoto E, Noguchi A, Mizushima Y. Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate. J. Biomed. Mater. Res. 56(2), 216-221 (2001).
36. Jeon O, Powell C, Solorio LD, Krebs MD, Alsberg E. Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels. J. Control. Release 154(3), 258-266 (2011).
37. Polk A, Amsden B, De Yao K, Peng T, Goosen MF. Controlled release of albumin from chitosan-alginate microcapsules. J. Pharm. Sci. 83(2), 178-185 (1994).
38. Chaubaroux C, Vrana E, Debry C et al. Collagen-based fibrillar multilayer films cross-linked by a natural agent. Biomacromolecules 13(7), 2128-2135 (2012).
39. Laham RJ, Sellke FW, Edelman ER et al. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial. Circulation 100(18), 1865-1871 (1999).
40. Moya ML, Cheng MH, Huang JJ et al. The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering. Biomaterials 31(10), 2816-2826 (2010).
41. Moya ML, Lucas S, Francis-Sedlak M, et al. Sustained delivery of FGF-1 increases vascular density in comparison to bolus administration Microvasc. Res. 78(2), 142-147 (2009).
42. McQuilling JP, Arenas-Herrera J, Childers C et al. New alginate microcapsule system for angiogenic protein delivery and immunoisolation of islets for transplantation in the rat omentum pouch. Transplant Proc. 43(9), 3262-3264 (2011).
43. Moya ML, Garfinkel MR, Liu X et al. Fibroblast growth factor-1 (FGF-1) loaded microbeads enhance local capillary neovascularization. J. Surg. Res. 160(2), 208-212 (2010).
44. Khanna O, Moya ML, Greisler HP, Opara EC, Brey EM. Multilayered microcapsules for the sustained-release of angiogenic proteins from encapsulated cells. Am. J. Surg. 200(5), 655-658 (2010).
45. Lopez JJ, Edelman ER, Stamler A et al. Angiogenic potential of perivascularly delivered aFGF in a porcine model of chronic myocardial ischemia. Am. J. Physiol. 274(3 Pt 2), H930-H936 (1998).
46. Gu F, Amsden B, Neufeld R. Sustained delivery of vascular endothelial growth factor with alginate beads. J. Control. Release 96(3), 463-472 (2004).
47. Elçin YM, Dixit V, Gitnick G. Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing. Artif. Organs 25(7), 558-565 (2001).
48. Li Q, Hou T, Zhao J, Xu J. Vascular endothelial growth factor release from alginate microspheres under simulated physiological compressive loading and the effect on human vascular endothelial cells. Tissue Eng. Part A 17(13-14), 1777-1785 (2011).
49. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat. Biotechnol. 19(11), 1029-1034 (2001).
50. Lee KY, Peters MC, Mooney DJ. Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. J. Control. Release 87(1-3), 49-56 (2003).
51. Cao L, Arany PR, Wang YS, Mooney DJ. Promoting angiogenesis via manipulation of VEGF responsiveness with notch signaling. Biomaterials 30(25), 4085-4093 (2009).
52. Jay SM, Shepherd BR, Andrejecsk JW, Kyriakides TR, Pober JS, Saltzman WM. Dual delivery of VEGF and MCP-1 to support endothelial cell transplantation for therapeutic vascularization. Biomaterials 31(11), 3054-3062 (2010).
53. Peirce SM, Price RJ, Skalak TC. Spatial and temporal control of angiogenesis and arterialization using focal applications of VEGF164 and Ang-1. Am. J. Physiol. Heart. Circ. Physiol. 286(3), H918-925 (2004).
54. Hirschi KK, Rohovsky SA, Beck LH, Smith SR, D'Amore PA. Endothelial cells modulate the proliferation of mural cell precursors via platelet-derived growth factor-BB and heterotypic cell contact. Circ. Res. 84(3), 298-305 (1999).
55. Hao X, Silva EA, Månsson-Broberg A et al. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. Cardiovasc. Res. 75(1), 178-185 (2007).
56. Sun Q, Silva EA, Wang A et al. Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis. Pharm. Res. 27(2), 264-271 (2010).
57. Ruvinov E, Leor J, Cohen S. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials 32(2), 565-578 (2011).
58. Banquet S, Gomez E, Nicol L et al. Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure. Circulation 124(9), 1059-1069 (2011).
59. Hill JM, Zalos G, Halcox JPJ et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348(7), 593-600 (2003).
60. Ingram DA, Mead LE, Tanaka H et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104(9), 2752-2760 (2004).
61. Critser PJ, Voytik-Harbin SL, Yoder MC. Isolating and defining cells to engineer human blood vessels. Cell Prolif. 44(Suppl 1), 15-21 (2011).
62. Hunt NC, Shelton RM, Henderson DJ, Grover LM. Calcium-alginate hydrogel-encapsulated fibroblasts provide sustained release of vascular endothelial growth factor. Tissue Eng. Part A doi:10.1089/ten. tea.2012.0197 (2012) (Epub ahead of print).
63. Wilson J, Pigott GH, Schoen FJ, Hench LL. Toxicology and biocompatibility of bioglasses. J. Biomed. Mater. Res. 15(6), 805-817 (1981).
64. Keshaw H, Forbes A, Day RM. Release of angiogenic growth factors from cells encapsulated in alginate beads with bioactive glass. Biomaterials 26(19), 4171-4179 (2005).
65. Devolder RJ, Zill AT, Jeong JH, Kong H. Microfabrication of proangiogenic cell-laden alginate-g-pyrrole hydrogels. Biomaterials 33(31), 7718-7726 (2012).
66. Orive G, De Castro M, Kong H-J et al. Bioactive cell-hydrogel microcapsules for cell-based drug delivery. J. Control. Release 135(3), 203-210 (2009).
67. Bidarra SJ, Barrias CC, Barbosa MA, Soares R, Granja PL. Immobilization of human mesenchymal stem cells within RGD-grafted alginate microspheres and assessment of their angiogenic potential. Biomacromolecules 11(8), 1956-1964 (2010).
68. Grellier M, Granja PL, Fricain J-C et al. The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials 30(19), 3271-3278 (2009).
69. Kim C, Chung S, Yuchun L et al. In vitro angiogenesis assay for the study of cell-encapsulation therapy. Lab Chip 12(16), 2942-2950 (2012).
70. Yu J, Du KT, Fang Q et al. The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. Biomaterials 31(27), 7012-7020 (2010
71. Chiu Y-C, Cheng M-H, Uriel S, Brey EM. Materials for engineering vascularized adipose tissue. J. Tissue Viability 20(2), 37-48 (2011).
72. Kim WS, Mooney DJ, Arany PR, Lee K, Huebsch N, Kim J. Adipose tissue engineering using injectable, oxidized alginate hydrogels. Tissue Eng. Part A 18(7-8), 737-743 (2012).
73. Man Y, Wang P, Guo Y et al. Angiogenic and osteogenic potential of platelet-rich plasma and adipose-derived stem cell laden alginate microspheres. Biomaterials 33(34), 8802-8811 (2012).
74. Doyle ME, Perley JP, Skalak TC. Bone marrow-derived progenitor cells augment venous remodeling in a mouse dorsal skinfold chamber model. PLoS ONE 7(2), e32815 (2012).
75. Vacharathit V, Silva EA, Mooney DJ. Viability and functionality of cells delivered from peptide conjugated scaffolds. Biomaterials 32(15), 3721-3728 (2011).
76. Jay SM, Shepherd BR, Bertram JP, Pober JS, Saltzman WM. Engineering of multifunctional gels integrating highly efficient growth factor delivery with endothelial cell transplantation. FASEB J. 22(8), 2949-2956 (2008).
77. Dvir T, Kedem A, Ruvinov E et al. Prevascularization of cardiac patch on the omentum improves its therapeutic outcome. Proc. Natl Acad. Sci. USA 106(35), 14990-14995 (2009).
78. Francis ME, Uriel S, Brey EM. Endothelial cell-matrix interactions in neovascularization. Tissue Eng. Part B Rev. 14(1), 19-32 (2008).
79. Bidarra SJ, Barrias CC, Fonseca KB, Barbosa MA, Soares RA, Granja PL. Injectable in situ crosslinkable RGD-modified alginate matrix for endothelial cells delivery. Biomaterials 32(31), 7897-7904 (2011).
80. Tsur-Gang O, Ruvinov E, Landa N et al. The effects of peptide-based modification of alginate on left ventricular remodeling and function after myocardial infarction. Biomaterials 30(2), 189-195 (2009).
81. Yamamoto M, James D, Li H, Butler J, Rafii S, Rabbany S. Generation of stable co-cultures of vascular cells in a honeycomb alginate scaffold. Tissue Eng. Part A 16(1), 299-308 (2010).
82. Sakai S, Inagaki H, Inamoto K, Taya M. Wrapping tissues with a pre-established cage-like layer composed of living cells. Biomaterials 33(28), 6721-6727 (2012).
83. Luo Y, Lode A, Gelinsky M. Direct plotting of three-dimensional hollow fiber scaffolds based on concentrated alginate pastes for tissue engineering. Adv. Healthc. Mater. doi:10.1002/adhm.201200303 (2012) (Epub ahead of print).
84. Sapir Y, Cohen S, Friedman G, Polyak B. The promotion of in vitro vessel-like organization of endothelial cells in magnetically responsive alginate scaffolds. Biomaterials 33(16), 4100-4109 (2012).